diff --git a/README.md b/README.md index 5d6b007..bedfee2 100644 --- a/README.md +++ b/README.md @@ -34,7 +34,7 @@ The COVID-19 IFR curves represent these estimates: 1. [Gudbjartsson et al.: Humoral Immune Response to SARS-CoV-2 in Iceland](https://www.nejm.org/doi/full/10.1056/NEJMoa2026116), specifically [Supplementary Appendix 1](https://www.nejm.org/doi/suppl/10.1056/NEJMoa2026116/suppl_file/nejmoa2026116_appendix_1.pdf) (table S7) 1. [PHAS - Public Health Agency of Sweden: The infection fatality rate of COVID-19 in Stockholm – Technical report](https://www.folkhalsomyndigheten.se/contentassets/53c0dc391be54f5d959ead9131edb771/infection-fatality-rate-covid-19-stockholm-technical-report.pdf) (table B.1) -1. [O’Driscoll et al.: Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries](https://www.medrxiv.org/content/10.1101/2020.08.24.20180851v1) (table S4) +1. [O’Driscoll et al.: Age-specific mortality and immunity patterns of SARS-CoV-2](https://www.nature.com/articles/s41586-020-2918-0) (table S3) 1. [Ward et al.: Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults](https://www.medrxiv.org/content/10.1101/2020.08.12.20173690v2), specifically [Supplementary Appendix](https://www.medrxiv.org/highwire/filestream/93745/field_highwire_adjunct_files/0/2020.08.12.20173690-1.docx) (table S2a, column "Based on confirmed COVID-19 deaths") 1. [Yang et al.: Estimating the infection fatality risk of COVID-19 in New York City during the spring 2020 pandemic wave](https://www.medrxiv.org/content/10.1101/2020.06.27.20141689v2) (table 1) diff --git a/covid_vs_flu.png b/covid_vs_flu.png index 7ffc488..1eba4c1 100644 Binary files a/covid_vs_flu.png and b/covid_vs_flu.png differ diff --git a/covid_vs_flu.py b/covid_vs_flu.py index 00034c2..c3098fe 100755 --- a/covid_vs_flu.py +++ b/covid_vs_flu.py @@ -137,27 +137,29 @@ ifrs_covid = [ (90,maxage): 16.21, }), - # O’Driscoll et al.: Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries - # https://www.medrxiv.org/content/10.1101/2020.08.24.20180851v1 - # (table S4) + # O’Driscoll et al.: Age-specific mortality and immunity patterns of SARS-CoV-2 + # https://www.nature.com/articles/s41586-020-2918-0 + # Supplementary information + # https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-020-2918-0/MediaObjects/41586_2020_2918_MOESM1_ESM.pdf + # (table S3) ('O’Driscoll', { - (0,4): 0.002, - (5,9): 0, - (10,14): 0, - (15,19): 0.002, - (20,24): 0.004, - (25,29): 0.009, - (30,34): 0.017, - (35,39): 0.029, - (40,44): 0.053, - (45,49): 0.086, - (50,54): 0.154, - (55,59): 0.241, - (60,64): 0.359, - (65,69): 0.642, - (70,74): 1.076, - (75,79): 2.276, - (80,maxage): 7.274, + (0,4): 0.003, + (5,9): 0.001, + (10,14): 0.001, + (15,19): 0.003, + (20,24): 0.006, + (25,29): 0.013, + (30,34): 0.024, + (35,39): 0.040, + (40,44): 0.075, + (45,49): 0.121, + (50,54): 0.207, + (55,59): 0.323, + (60,64): 0.456, + (65,69): 1.075, + (70,74): 1.674, + (75,79): 3.203, + (80,maxage): 8.292, }), # Ward et al.: Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults @@ -388,8 +390,8 @@ def main(): fig.suptitle('Infection Fatality Ratio of COVID-19 vs. Seasonal Influenza') ax.text(0, -0.11, 'Source: https://github.com/mbevand/covid19-age-stratified-ifr\n' - 'Note: the vertical lines on two COVID-19 IFR curves (Poletti and O’Driscoll) are caused by the IFR being\n' - 'estimated to be zero by Poletti for age groups 0-19 and 20-49, and by O’Driscoll for 5-9 and 10-14.\n', + 'Note: the vertical lines on one COVID-19 IFR curve (Poletti) are caused by the IFR being\n' + 'estimated to be zero for age groups 0-19 and 20-49.\n', transform=ax.transAxes, fontsize='small', verticalalignment='top', ) ax.text(1, 1, 'Created by: Marc Bevand — @zorinaq',